Insider · CIK 0001624670

Kelly David George

Reports to the SEC for 2 companies · DUBLIN, L2

sec.gov

Transactions

Companies

Filings

CIK

0001624670

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-15	ITRMIterum Therapeutics plc · Share Option (Right to Buy)A Award	Director	AAward	+647K sh	—	—	647,059
2021-06-23	ITRMIterum Therapeutics plc · Stock Option (Right to Buy)A Award	Director	AAward	+64.7K sh	—	—	64,706
2020-06-13	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+11.4K sh	—	—	37,108
2020-06-13	ITRMIterum Therapeutics plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.4K sh	—	—	0
2020-06-10	ITRMIterum Therapeutics plc · Stock Option (Right to Buy)A Award	Director	AAward	+62.8K sh	—	—	62,840
2019-06-13	ITRMIterum Therapeutics plc · Restricted Stock UnitsA Award	Director	AAward	+11.4K sh	—	—	11,406
2019-05-24	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+6,154 sh	—	—	25,702
2019-05-24	ITRMIterum Therapeutics plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,154 sh	—	—	0
2018-11-30	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+10K sh	$6.29	+$62.9K	19,548
2018-05-30	ITRMIterum Therapeutics plcC Conversion	Director	CConversion	+9,548 sh	—	—	9,548
2018-05-30	ITRMIterum Therapeutics plc · Series A Preferred SharesC Conversion	Director	CConversion	−9,548 sh	—	—	0
2018-05-24	ITRMIterum Therapeutics plc · Restricted Stock UnitsA Award	Director	AAward	+6,154 sh	—	—	6,154
2016-03-23	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Company Secretary	MExercise/Conversion	+19.3K sh	—	—	19,250
2016-03-23	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	EVP, Company Secretary	MExercise/Conversion	−19.3K sh	—	—	57,750
2015-05-06	Horizon Therapeutics Public Ltd CoPerformance Share Units (PSU)A Award	EVP, Company Secretary	AAward	+558K sh	—	—	558,000
2015-03-23	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP, Company Secretary	AAward	+173K sh	—	—	173,000
2015-03-23	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	EVP, Company Secretary	AAward	+77K sh	—	—	77,000
2015-03-23	Horizon Therapeutics Public Ltd CoPerformance Share Units (PSU)A Award	EVP, Company Secretary	AAward	+186K sh	—	—	186,000

Recent filings

Accepted (ET)
Jun 174
Kelly David George0001209191-22-037944
SEC(opens sec.gov)
Jun 254
Kelly David George0000899243-21-025957
SEC(opens sec.gov)
Jun 164
Kelly David George0000899243-20-016644
SEC(opens sec.gov)
Jun 124
Kelly David George0000899243-20-016405
SEC(opens sec.gov)
Jun 174
Kelly David George0000899243-19-017209
SEC(opens sec.gov)
May 294
Kelly David George0000899243-19-015011
SEC(opens sec.gov)
Dec 44
Kelly David George0001209191-18-060998
SEC(opens sec.gov)
May 304
Kelly David George0001209191-18-034200
SEC(opens sec.gov)
May 294
Kelly David George0001209191-18-033877
SEC(opens sec.gov)
Mar 244
Horizon Pharma plc0001209191-16-110485
SEC(opens sec.gov)
May 84
Horizon Pharma plc0001209191-15-040710
SEC(opens sec.gov)
Mar 254
Horizon Pharma plc0001209191-15-029409
SEC(opens sec.gov)

Companies

Address

C/O HORIZON PHARMA PLC ADELAIDE CHAMBERS, PETER STREET

DUBLIN, L2, 8